Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis

Clinical and Experimental Immunology

Volumn 115, Issue 1, 1999, Pages 95-102

  Sakiniene, Egidija ^a   Bremell, T ^a   Tarkowski, A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Arthritis infectious; Cobra venom factor; Complement; Staphylococcus aureus

Indexed keywords

COBROTOXIN; STAPHYLOCOCCUS TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ARTHRITIS; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PREVALENCE; PRIORITY JOURNAL; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SYNOVITIS;

ANIMALS; ARTHRITIS, REACTIVE; COBRA VENOMS; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT SYSTEM PROTEINS; DIETARY FATS, UNSATURATED; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-6; MALE; MICE; MICE, INBRED STRAINS; PHAGOCYTOSIS; PLANT OILS; STAPHYLOCOCCAL INFECTIONS;

EID: 0032916332     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00771.x     Document Type: Article

References (37)

1. 1 Goldenberg DL. Bacterial arthritis. Tn: Kelly WO, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: W.B. Saunders Cooy, 1989:1567-85.
2. 2 Bremell T, Lange S, Yacoub A et al. Experimental Staphylococcus aureus arthritis in mice. Infect Immun. 1991; 59:2615-23.
3. 3 Abdelnour A, Bremell T, Holmdahl R et al. Role of T lymphocytes in experimental Staphylococcus aureus arthritis. Scand J Immunol. 1994; 39:403-8.
4. 4 Bremell T, Lange S, Holmdahl R et al. Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun. 1994; 62:2334-44.
5. 5 Abdelnour A, Bremell T, Holmdahl R et al. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1 producing staphylococci. Eur J Immunol 1994; 24:1161-6.
6. 6 Abdelnour A, Bremell T, Tarkowski A. Toxic shock syndrome toxin-1 contributes to the arthritogenicity of Staphylococcus aureus. J Infect Dis 1994; 170:94-99.
7. 7 Zhao Y-X, Ljungdahl Å, Olsson T et al. In situ hybridization analysis of synovial and systemic cytokine mRNA expression in superantigen-triggered Staphylococcus aureus arthritis. Arthritis Rheum 1996; 39:959-67.
8. 8 Gowen M, Wood DD, Ihrie EJ et al. An interleukin 1 like factor stimulates bone resorption in vitro. Nature 1983; 306:378-80.
9. 9 Zhao Y-X, Abdelnour A, Holmdahl R et al. Mice with the Xid B cell defect are less susceptible to developing Staphylococcus aureus induced arthritis. J Immunol 1995; 155:2067-76.
10. 10 Bremell T, Holmdahl R, Tarkowski A. Protective role of sialophorin (CD43) expressing cells in experimental Staphylococcus aureus infection. Infect Immun 1994; 62:4637-40.
11. 11 Verdrengh M, Tarkowski A. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 1997; 65:2517-21.
12. 12 Goldstein IM. Complement. Biologically active products. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation. Basic principles and clinical correlates. New York: Raven Press, 1992:63-80.
13. 13 Frank MM, Fries LF. The role of complement in defence against bacterial disease. Baillieres's Clin Immunol Allergy 1988; 2:335-61.
14. 14 Ward PA, Zvaifler NJ. Complement-derived leukotactic factors in inflammatory synovial fluids of humans. J Clin Invest 1971; 50:606-16.
15. 15 Theofilopoulos AN, Carson DA, Tavassoli M et al. Evidence for the presence of receptors for C3 and IgG Fc on human synovial cells. Arthritis Rheum 1980; 23:1-19.
16. 16 Tarkowski A, Trollmo C, Seifert PS et al. Expression of decay-accelerating factor on synovial lining cells in inflammatory and degenerative arthritides. Rheumatol Int 1992; 12:201-5.
17. 17 Gaede KI, Baumeister E, Heesemann J. Decomplementation by cobra venom factor suppresses Yersinia-induced arthritis. Infect Immun 1995; 63:3697-701.
18. 18 Bremell T, Lange S, Svensson L et al. Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum 1990; 33:1739-44.
19. 19 Abdelnour A, Arvidson S, Bremell T et al. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 1993; 61:3879-85.
20. 20 Vogel CW. Cobra venom factor: the complement-activating protein of cobra venom. In: Tu AT, ed. Reptile venoms and toxins, handbook of natural toxins. New York: Marcel Dekker Inc., 1991:147-88.
21. 21 Lansdorp PM, Aarden LA, Calafat J et al. A growth factor dependent B-cell hybridoma. Curr Top Microbiol Immunol 1986; 132:105-13.
22. 22 Aarden LA, Groot ERD, Shaap OL et al. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987; 17:1411-6.
23. 23 Helle M, Boeije L, Aarden LA. Functional discrimination between interleukin-6 and interleukin-1. Eur J Immunol 1988; 18:1535-40.
24. 24 Brakenhoff JPJ, Groot ERD, Evers RF et al. Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol 1987; 139:4116-21.
25. 25 Bremell T, Abdelnour A, Tarkowski A. Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun 1992; 60:2976-85.
26. 26 Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2:235-54.
27. 27 Lue C, Tarkowski A, Mestecky J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases both scrum and secretory anti-pneumococcal antibodies. J Immunol 1988; 140:3793-3800.
28. 28 Russel MW, Brown TA, Radl J et al. Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies. J Immunol Methods 1986; 87:87-93.
29. + T lymphocytes. Cell Immunol 1995; 161:28-33.
30. 30 Goldenberg DL, Cohen AS. Synovial membrane histopathology in the different diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease. Medicine 1978; 57:239-52.
31. 31 Josefsson E, Tarkowski A, Carlsten H. Anti-inflammatory properties of estrogen. Cell Immunol 1992; 142:67-78.
32. 32 Josefsson E, Carlsten H, Tarkowski A. Neutrophil mediated inflammatory response in murine lupus. Autoimmunity 1993; 14:251-7.
33. 33 Frank MM. Animal models for complement deficiencies. J Clin Immunol 1995, 15:113S-121S.
34. 34 Ferrante A, Martin AJ, Bates EJ et al. Killing of Staphylococcus aureus by tumor necrosis factor-α-activated neutrophils. J Immunol 1993; 151:4821-8.
35. 35 Tanoue M, Yoshizawa Y, Sato T et al. The role of complement-derived chemotactic factors in lung injury induced by preformed immune complexes. Int Arch Allergy Immunol 1993; 101:47-51.
36. 36 Tuomanen E, Hengstler B, Zak O et al. The role of complement in inflammation during experimental pneumococcal meningitis. Microb Pathogen 1986; 1:15-32.
37. 37 Heyman B. The role of complement receptors in the regulation of the immune response. In: Erdei A, ed. New aspects of complement structure and function. Austin, Texas: R. G. Landes Co., 1994.